Stockholm, Sweden, January 31, 2012
During January, 33,799 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.
The total number of shares in Elekta as of January 31, 2012 amounts to 94,803,562 divided between 3,562,500 A shares and 91,241,062 B shares.
One A share entitles the holder to ten votes and one B share to one vote.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.